AbbVie [clinicaltrials_resource:665d7d8b26be61d84f23b5abd7000da9]
Kori Wallace, MD [clinicaltrials_resource:01599d68186c1431867e48166ff983a1]Mogana Sivalingam, MD [clinicaltrials_resource:01e6c4344aa82ae40f623673cbaf452e]Daniel Cohen, MD [clinicaltrials_resource:02c958f4b20748159e95d90f649d09a7]Mark McKee, MD [clinicaltrials_resource:036a1476a0af695a64e00da6434ea8c8]Yan Luo, MD [clinicaltrials_resource:04714fdb6d532b91ecd7e4c1af2c1a56]Mark D. McKee, MD [clinicaltrials_resource:05d23400d74c78b59fe4dda42d339b4a]Steven Pulaski, MS [clinicaltrials_resource:05ec066c8b470130a528ab536845baf1]Paul M Peloso, MD [clinicaltrials_resource:07220015a9976d2822f965264409957f]Philip Komarnitsky, MD [clinicaltrials_resource:07bd8bf13822eedf6d408e63247a4c86]Andrew Campbell, MD [clinicaltrials_resource:0837e9aa6229729485a2326616972ebc]Armen Asatryan, MD [clinicaltrials_resource:08bc157ab7f8eb45dfdf04ebc32bc1be]Andrew Payne, PhD [clinicaltrials_resource:09317d6a2a6249c2fedbc0871b442e2b]Stacie P Shepherd, MD [clinicaltrials_resource:0cda49b598afcbbe7410f85d0a543a7f]Eva Dahl, MD [clinicaltrials_resource:0d00bdd8b4a2635a29bc34cad4bea8cd]Martin Okun, MD [clinicaltrials_resource:0d36007a9194f96b37f7aec82279280f]Paul M Peloso, MD [clinicaltrials_resource:0d9e10e9e4ac541d75803c0aa7de48e9]Marc-André Raymond, PhD [clinicaltrials_resource:0e27196ef816c25f02446e142740c102]Katia Alves, MD [clinicaltrials_resource:0f9ee43b50a6ffc30e7dc1bd3e0da5ed]Holly Read, MD [clinicaltrials_resource:0fa534e5c598ccac64bec6b023bbfe17]Eric Cohen, MD [clinicaltrials_resource:1018dd808371785be596f5c444486092]Louie Naumovski, MD [clinicaltrials_resource:109c6fe683ec1eb1ac90a58e4a5deec2]John Hayslip, MD [clinicaltrials_resource:10e39a3b3bdb24a921d0ccb625e7d7f5]Eoin Coakley, MD [clinicaltrials_resource:114350ddab570158751e03484559dd14]John Hayslip, MD [clinicaltrials_resource:12625ad0107fdb3a92fd550a92624c90]Roger Trinh, MD [clinicaltrials_resource:12a375ba5903811a013f85b5a57fad7a]Su Y Kim, MD [clinicaltrials_resource:142489707b9799743bbb9662720e7ec5]Jeffrey Enejosa, MD [clinicaltrials_resource:1520bce44fe031b3f08b2c3b1fd83c1b]Abraham Kroon, MD, PhD [clinicaltrials_resource:1526800ff7e961797416facd992a3b32]Philip Komarnitsky, MD [clinicaltrials_resource:168054711b6530bd4cedf47595e5b76d]Pedro Quintana Diez, MD [clinicaltrials_resource:16923b7bb75bb25017eda1b76b5f544c]Yan Luo, MD [clinicaltrials_resource:1819c7ba4789a04745db96d01480718b]Koray Onuk [clinicaltrials_resource:1a6d21e075fdec7660c19e5ccde6417d]Armen Asatryan, MD [clinicaltrials_resource:1b052eaef3ceb85475945b23c99d99dc]Emily Dumas, PhD [clinicaltrials_resource:1c4d40405bea9f2862bd98f79926c1fe]Paul M Peloso, MD [clinicaltrials_resource:1d0a9f0f4da78396ee65933b724fe9be]Robert Padley, MD [clinicaltrials_resource:1d6a04c154495d8eaf666440942e42ec]Eoin Coakley, MD [clinicaltrials_resource:1df1d3c406711df4fd2b903cf77b449b]Mark D McKee, MD [clinicaltrials_resource:1ea9718bc6c66fc6196eaee159145d72]Mark D McKee, MD [clinicaltrials_resource:1ed3c807ff54eaa2d30fcb7ebf7cae0d]David Pugatch, MD [clinicaltrials_resource:1ed8295053d3cb61ba976fff3ff38de2]
affiliation [clinicaltrials_vocabulary:affiliation]
Assessment of Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, Plaque Psoriasis, Crohn's Disease and Ulcerative Colitis Patients´ Adherence Attitudes to Maintenance Therapy With a Scheduled Adalimumab Treatment in Routine Clinical Practice [clinicaltrials:NCT01768858]clinicaltrials:NCT01858519A Study of the Efficacy of ABT-199 in Subjects With Relapsed/Refractory or Previously Untreated Chronic Lymphocytic Leukemia With the 17p Deletion [clinicaltrials:NCT01889186]A Phase 3 Study of SME3110 in Pediatric/Adolescent Subjects With Obsessive Compulsive Disorder [clinicaltrials:NCT01933919]clinicaltrials:NCT01960881clinicaltrials:NCT01969669clinicaltrials:NCT01969682An Extension Study of ABT-199 in Subjects With Advanced Non-Hodgkin's Lymphoma [clinicaltrials:NCT01969695]A Phase 2 Study of ABT-199 in Subjects With Acute Myelogenous Leukemia (AML) [clinicaltrials:NCT01994837]clinicaltrials:NCT02032277A Pharmacokinetic Study to Access How the Body Absorbs and Removes ABT-199 in Adults With Non-Hodgkin's Lymphoma [clinicaltrials:NCT02095574]clinicaltrials:NCT02141282clinicaltrials:NCT02148718clinicaltrials:NCT02203773clinicaltrials:NCT02265731clinicaltrials:NCT02287233clinicaltrials:NCT02343406clinicaltrials:NCT02470585Impact of Adalimumab on Patient-reported Outcomes in Ulcerative Colitis [clinicaltrials:NCT02506179]
collaborator [clinicaltrials_vocabulary:collaborator]
Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain [clinicaltrials:NCT01760954]Assessment of Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, Plaque Psoriasis, Crohn's Disease and Ulcerative Colitis Patients´ Adherence Attitudes to Maintenance Therapy With a Scheduled Adalimumab Treatment in Routine Clinical Practice [clinicaltrials:NCT01768858]A Safety and Efficacy Trial of Multiple Dosing Regimens of ABT-719 for the Prevention of Acute Kidney Injury in Subjects Undergoing High Risk Cardiac Surgery [clinicaltrials:NCT01777165]clinicaltrials:NCT01782495Special Investigation in Rheumatoid Arthritis Patient Showing Rapid Progression of Structural Damage of the Joints, Who Have no Prior History of Treatment With Disease-modifying Anti-rheumatic Drugs or Biological Agents [clinicaltrials:NCT01783730]clinicaltrials:NCT01800695clinicaltrials:NCT01808118Safety and Efficacy in Premenopausal Women With Heavy Menstrual Bleeding (HMB) Associated With Uterine Fibroids (UF) [clinicaltrials:NCT01817530]clinicaltrials:NCT01833533Long-term Safety and Efficacy of ABT-126 in Subjects With Schizophrenia: An Extension Study for Subjects Completing Study M10-855 (NCT01655680) [clinicaltrials:NCT01834638]Study in Ankylosing Spondylitis (AS) and Psoriatic Arthritis (PsA) Patients to Evaluate Work Productivity Before and After the Start of Adalimumab Therapy in Daily Practice in Belgium [clinicaltrials:NCT01845818]A Long-Term Registry of Humira® (Adalimumab) in Patients With Moderately to Severely Active Ulcerative Colitis (UC) [clinicaltrials:NCT01848561]A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Multiple Subcutaneous Injections of ABT-122 in Subjects With Rheumatoid Arthritis [clinicaltrials:NCT01853033]A Study to Evaluate the Safety, Pharmacokinetics and Oral Bio Availability of Veliparib in Subjects With Solid Tumors [clinicaltrials:NCT01853306]A Study to Evaluate the Efficacy and Safety of Three Experimental Drugs Compared With Telaprevir (a Licensed Product) for Treatment of Chronic Hepatitis C Infection in Treatment-experienced Adults [clinicaltrials:NCT01854528]clinicaltrials:NCT01854697clinicaltrials:NCT01858519clinicaltrials:NCT01858532Improvement of Work Productivity and Quality of Life With Anti-Tumor Necrosis Factor (TNF) Therapies Used in Crohn's Disease in Routine Clinical Practice in Turkey [clinicaltrials:NCT01860846]A Study of the Efficacy of ABT-199 in Subjects With Relapsed/Refractory or Previously Untreated Chronic Lymphocytic Leukemia With the 17p Deletion [clinicaltrials:NCT01889186]A Safety and Efficacy Trial of Multiple Dosing Regimens of ABT-719 for the Prevention of Acute Kidney Injury in Subjects Undergoing High Risk Surgery [clinicaltrials:NCT01897519]Safety, Tolerability, and Pharmacokinetics of ABT-354 in Subjects With Mild-to-Moderate Alzheimer's Disease on Stable Doses of Acetylcholinesterase Inhibitors [clinicaltrials:NCT01908010]clinicaltrials:NCT01911845A Global Phase 3 Study to Evaluate the Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain [clinicaltrials:NCT01931670]A Phase 3 Study of SME3110 in Pediatric/Adolescent Subjects With Obsessive Compulsive Disorder [clinicaltrials:NCT01933919]clinicaltrials:NCT01939197Study of ABT-165 in Subjects With Advanced Solid Tumors [clinicaltrials:NCT01946074]Special Investigation in Patients With Ulcerative Colitis [clinicaltrials:NCT01947816]Levodopa Carbidopa Intestinal Gel Home Titration Using Telemedicine: Evaluation of Use of Resources [clinicaltrials:NCT01956032]clinicaltrials:NCT01958827Special Investigation in Patients With Intestinal Behcet's Disease (All Case Investigation) [clinicaltrials:NCT01960790]A Study to Assess the Efficacy, Safety and Tolerability of ABT-SLV187 Monotherapy in Subjects With Advanced Parkinson's Disease (PD) and Persistent Motor Complications, Despite Optimized Treatment With Available Anti-Parkinsonian Medications [clinicaltrials:NCT01960842]clinicaltrials:NCT01960855clinicaltrials:NCT01960881clinicaltrials:NCT01969669clinicaltrials:NCT01969682An Extension Study of ABT-199 in Subjects With Advanced Non-Hodgkin's Lymphoma [clinicaltrials:NCT01969695]A Phase 2 Study of ABT-199 in Subjects With Acute Myelogenous Leukemia (AML) [clinicaltrials:NCT01994837]A Study to Evaluate the Safety and Antiviral Effect of Multiple Doses of ABT-493 and ABT-530 in Adults With Genotype 1 Hepatitis C Virus (HCV) [clinicaltrials:NCT01995071]A Study to Evaluate the Effects of Veliparib on Heart Rhythms in Patients With Solid Tumors [clinicaltrials:NCT02009631]
lead sponsor [clinicaltrials_vocabulary:lead-sponsor]
Safety and Effectiveness of Two Doses of ABT-874 as Compared to Placebo in Subjects With Multiple Sclerosis (MS) [clinicaltrials:NCT00086671]clinicaltrials:NCT00195663Safety of Lopinavir/Ritonavir (Kaletra) in HIV/HCV Co-infected Subjects vs Baseline Liver Biopsy Metavir Score [clinicaltrials:NCT00234975]Efficacy and Safety of ABT-874 in Subjects With Moderate to Severe Chronic Plaque Psoriasis [clinicaltrials:NCT00292396]A Phase 1/2 Study Evaluating ABT-751 in Combination With Alimta in Advanced Non-Small Cell Lung Cancer [clinicaltrials:NCT00297089]clinicaltrials:NCT00335153clinicaltrials:NCT00357994clinicaltrials:NCT00360568A Study of Volociximab in Combination With Gemcitabine in Metastatic Pancreatic Cancer [clinicaltrials:NCT00401570]clinicaltrials:NCT00406809Safety and Efficacy Study of NBI-56418 in Endometriosis [clinicaltrials:NCT00437658]A Safety and Tolerability Study of ABT-089 in Adults With Attention Deficit-Hyperactivity Disorder (ADHD) [clinicaltrials:NCT00443391]clinicaltrials:NCT00445198A Phase 1/2a Study of ABT-263 in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia [clinicaltrials:NCT00481091]Study of ABT-869 in Subjects With Advanced Renal Cell Carcinoma Who Have Previously Received Treatment With Sunitinib [clinicaltrials:NCT00486538]clinicaltrials:NCT00497146Safety and Efficacy Study in Subjects With Diabetic Neuropathic Pain [clinicaltrials:NCT00507936]Study of ABT-869 in Subjects With Advanced Non-small Cell Lung Cancer (NSCLC) [clinicaltrials:NCT00517790]Phase 2 Study of ABT-869 in Advanced Hepatocellular Carcinoma (HCC) [clinicaltrials:NCT00517920]A Long-Term Registry of Humira® (Adalimumab) in Subjects With Moderately to Severely Active Crohn's Disease (CD) [clinicaltrials:NCT00524537]A Safety and Efficacy Study of ABT-089 in Children With Attention-Deficit/Hyperactivity Disorder (ADHD) [clinicaltrials:NCT00528697]A Safety and Efficacy Study in Subjects With Diabetic Neuropathic Pain [clinicaltrials:NCT00548925]A Study Comparing the Safety and Efficacy of Two Dosing Regimens of ABT-874 to Placebo in Subjects With Moderate to Severe Chronic Plaque Psoriasis [clinicaltrials:NCT00570986]clinicaltrials:NCT00573794clinicaltrials:NCT00616772An Efficacy and Safety Study of NBI-56418 in Endometriosis [clinicaltrials:NCT00619866]Open Label Continuation Study in Moderate to Severe Psoriasis [clinicaltrials:NCT00626002]clinicaltrials:NCT00635193Safety, Tolerability and Efficacy Study of ABT-089 in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD) [clinicaltrials:NCT00640185]Safety and Tolerability Study of ABT-089 in Children With Attention-Deficit/Hyperactivity Disorder (ADHD) [clinicaltrials:NCT00640419]clinicaltrials:NCT00645177Safety and Efficacy of Kaletra in ARV Therapy Experienced Patients [clinicaltrials:NCT00648999]A Phase I Study of ABT-888 in Combination With Conventional Whole Brain Radiation Therapy (WBRT) in Cancer Patients With Brain Metastases [clinicaltrials:NCT00649207]clinicaltrials:NCT00660387clinicaltrials:NCT00660673clinicaltrials:NCT00667446clinicaltrials:NCT00679731clinicaltrials:NCT00686374Long Term Safety and Tolerability Study of ABT-089 in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD) [clinicaltrials:NCT00686933]Study Comparing the Efficacy and Safety of ABT-874 to Etanercept and Placebo in Subjects With Moderate to Severe Chronic Plaque Psoriasis [clinicaltrials:NCT00691964]
source [clinicaltrials_vocabulary:source]
AbbVie [clinicaltrials_resource:665d7d8b26be61d84f23b5abd7000da9]
Bio2RDF identifier
665d7d8b26be61d84f23b5abd7000da9
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:665d7d8b26be61d84f23b5abd7000da9
organization [clinicaltrials_vocabulary:organization]
identifier
clinicaltrials_resource:665d7d8b26be61d84f23b5abd7000da9
title
AbbVie
@en
type
label
AbbVie [clinicaltrials_resource:665d7d8b26be61d84f23b5abd7000da9]
@en